The Altman Network

Investigation Events

Persons of Interest and Profiles

Sam Altman Self-Dealing & Conflict Architecture

Spark Capital

Led Anthropic’s $450 million Series C and placed a General Partner on Anthropic’s board of directors; invested in Formation Bio’s venture round through GP William Reed; hired OpenAI’s former Head of Product as a venture partner; co-invested with the OpenAI Startup Fund. The only known venture firm with board-level governance at OpenAI’s primary competitor AND an investment in a company that partners commercially with OpenAI.

Spark Capital Partners, LLC is a multi-stage venture capital firm founded in 2005 by Bijan Sabet, Paul Conway, Santo Politi, and Todd Dagres. The firm is headquartered in San Francisco with additional offices in New York and Boston. Spark manages approximately $15 billion in assets and is currently led by key partners including Alex Finkelstein, Nabeel Hyatt, Jeremy Philips, Santo Politi, Yasmin Razavi, Will Reed, Bijan Sabet, and Kevin Thau. The firm has raised eight early-stage funds ($265M in 2005 through $700M in 2024) and five growth funds ($375M in 2014 through $1.4B in 2024) [1].

Spark Capital built its early reputation through prescient investments in social media and consumer technology, including Twitter (one of the earliest institutional investors), Oculus (VR headset, acquired by Facebook for $2B), Slack, Tumblr, Trello, Coinbase, Postmates, and Discord. The firm’s evolution from consumer internet to AI and enterprise software accelerated in 2023 when it dramatically increased its AI investment activity, most visibly through its Anthropic relationship [2].

Formation Bio: The Reed Investment

Spark Capital invested in TrialSpark’s October 2018 venture round through General Partner William Reed. Reed’s investment focus areas include AI, healthcare, fintech, and vertical software — and his background prior to Spark included investment banking at Bank of America Merrill Lynch and investing at Welsh, Carson, Anderson & Stowe, a healthcare-focused private equity firm. This healthcare PE experience makes Reed one of the few Formation Bio investors with institutional-grade healthcare deal-making expertise [3] [4].

Spark Capital is listed alongside Thrive Capital, Sequoia Capital, Sound Ventures, Felicis Ventures (Wesley Chan), TQ Ventures, and Cherubic Ventures in the October 2018 venture round. The firm’s presence in later Formation Bio rounds (Series C in September 2021, Series D in June 2024) has not been consistently confirmed across all data sources, though some investor listings include Spark in later rounds. Whether Spark maintained, increased, or exited its position through the company’s evolution from clinical trial tech into pharmaceutical acquisition is an open question [5].

Anthropic: Board-Level Governance

In May 2023, Spark Capital led Anthropic’s $450 million Series C funding round at a valuation of approximately $4.1 billion. As part of the round, Spark General Partner Yasmin Razavi joined Anthropic’s board of directors. Razavi focuses on growth-stage software investments and now holds a formal governance role at the company widely regarded as OpenAI’s primary competitor [6] [7].

Anthropic was founded in 2021 by former OpenAI employees, principally siblings Dario Amodei (CEO, formerly OpenAI VP of Research) and Daniela Amodei (President). The founding was motivated by disagreements with OpenAI’s direction, particularly regarding safety practices and the pace of commercialization. Anthropic has positioned itself as the safety-focused alternative to OpenAI, making the competitive relationship foundational rather than merely commercial [8].

Other participants in the Anthropic Series C included Google (Anthropic’s preferred cloud provider), Salesforce Ventures, Zoom Ventures, Sound Ventures (Ashton Kutcher/Guy Oseary), and Menlo Ventures. The presence of Sound Ventures in both the Anthropic Series C and the Formation Bio venture round means two firms from Formation Bio’s cap table — Spark and Sound — co-invested in Anthropic in the same round [6].

Fraser Kelton: The Three-Way Bridge

Shortly before leading the Anthropic Series C, Spark Capital hired Fraser Kelton as a venture partner. Kelton’s career path is the single most concentrated instance of cross-competitive movement documented in this investigation:

  1. OpenAI: Head of Product — led product strategy for ChatGPT and related products
  2. Anthropic: Personal investor — put his own money into OpenAI’s primary competitor
  3. Spark Capital: Venture partner — joined the firm that then led Anthropic’s Series C and invested in Formation Bio (which partners with OpenAI)

A single individual who shaped OpenAI’s product roadmap, bet his personal capital on OpenAI’s competitor, and then joined the venture firm that governs that competitor while holding a stake in a company that does commercial business with OpenAI. Kelton carries institutional knowledge from OpenAI (product strategy, competitive positioning, organizational dynamics) into a firm that has board-level access to Anthropic and portfolio exposure to OpenAI’s commercial partners [9] [10].

TechCrunch noted the timing directly: “Perhaps not coincidentally, the Series C also comes after Spark Capital’s hiring of Fraser Kelton, the former head of product at OpenAI, as a venture partner. Spark was an early investor in Anthropic” [6].

OpenAI Startup Fund Co-Investment

Spark Capital co-invested with the OpenAI Startup Fund in Descript’s $50 million Series C round in late 2022, alongside Andreessen Horowitz, Redpoint Ventures, and former Y Combinator partner Daniel Gross. The OpenAI Startup Fund is managed by a team that includes Brad Lightcap — the same OpenAI COO who serves as the named recusal proxy for Altman’s conflicts of interest and the quoted spokesperson for the Muse partnership with Formation Bio [11] [12].

This co-investment establishes a direct financial relationship between Spark Capital and the OpenAI Startup Fund apparatus. When Spark later invested in Formation Bio (which partners with OpenAI) and led Anthropic’s Series C (OpenAI’s competitor), the pre-existing co-investment relationship with the OpenAI Startup Fund adds another layer to the cross-competitive positioning.

The OpenAI Startup Fund also co-invested with Thrive Capital in Chai Discovery, a drug discovery AI startup, in September 2025. This connects the OpenAI Startup Fund’s biotech AI portfolio directly to Thrive Capital — Formation Bio’s longest-standing institutional investor and OpenAI’s largest external shareholder. The drug discovery AI space is beginning to show the same investor overlap patterns as the foundation model space. Additionally, the OpenAI Startup Fund co-founded Thrive AI Health with Arianna Huffington — a healthcare AI company operating in the same broad sector as Formation Bio, further demonstrating that the OpenAI ecosystem’s healthcare ambitions extend beyond the Muse partnership [11] [13].

The Structural Conflict

Spark Capital’s position across the AI landscape creates the deepest documented instance of cross-competitive conflict in this investigation:

SPARK CAPITAL ($15B AUM)
│
├── ANTHROPIC (Series C lead, $450M)
│   ├── Yasmin Razavi: GP, sits on Anthropic's BOARD
│   ├── Competitor to OpenAI
│   └── Founded by former OpenAI employees over safety disagreements
│
├── FORMATION BIO (venture round, William Reed)
│   ├── Partners commercially with OpenAI (Muse, Nov 2024)
│   ├── Altman holds personal $19M stake
│   ├── Lightcap (OpenAI COO → "special projects" under Altman, Apr 2026) is partnership spokesperson
│   └── Lightcap's crisis call to Kushner (Thrive/Formation Bio's longest backer) = personal bond
│
├── DESCRIPT (Series C, co-invested with OpenAI Startup Fund)
│   └── Direct financial relationship with Lightcap/OpenAI Fund
│
├── THRIVE AI HEALTH (OpenAI Startup Fund + Arianna Huffington)
│   └── Healthcare AI company in the OpenAI ecosystem — same sector as Formation Bio
│
└── FRASER KELTON (venture partner)
    ├── Former: OpenAI Head of Product
    └── Former: Personal Anthropic investor

Spark has a GP governing Anthropic’s board decisions while another GP invested in a company whose primary AI partner is OpenAI. A venture partner who shaped OpenAI’s product strategy now works alongside partners who govern OpenAI’s competitor. The firm co-invested alongside the OpenAI Startup Fund while simultaneously leading Anthropic’s largest funding round.

(Anthropic conflict flag: This is the most structurally concentrated instance of the cross-competitive conflict documented in the investigation. The conflict is not theoretical — it operates through specific, named individuals with governance roles, through co-investment relationships with competing fund vehicles, and through a venture partner whose career path bridges both sides of the divide. How Spark Capital manages information barriers between its Anthropic governance role, its Formation Bio position, its OpenAI Startup Fund co-investment relationship, and its venture partner’s prior institutional knowledge is a question that warrants examination.)

Network Position

Sound Ventures co-invested with Spark in both the Formation Bio venture round AND the Anthropic Series C. Two Formation Bio investors appearing together on both sides of the AI divide is a pattern, not a coincidence.

Thrive Capital co-invested with the OpenAI Startup Fund in Chai Discovery (drug discovery AI), connecting the biotech-AI investment thesis to Formation Bio’s longest institutional investor and OpenAI’s largest external shareholder.

Sequoia Capital is Spark’s peer in several respects: both are multi-billion-dollar generalist funds with Formation Bio positions and AI investments. But Sequoia does not have a board seat at Anthropic — making Spark’s cross-competitive governance position unique.

The Lightcap Thread: Brad Lightcap is the single individual who connects Spark Capital’s various OpenAI-adjacent positions, and his role has evolved in ways that deepen rather than resolve the structural conflicts:

  • Late 2022: Lightcap, as OpenAI Startup Fund partner, co-invests with Spark Capital in Descript’s Series C. This establishes a direct financial relationship between Spark and Lightcap’s fund vehicle.
  • November 17, 2023: When Altman is fired, Lightcap’s first call is to Joshua Kushner (Thrive Capital) — Formation Bio’s longest institutional investor and also a Spark Capital co-investor in Formation Bio. Lightcap’s crisis response goes first to the investor who connects Spark’s portfolio company to OpenAI’s largest external shareholder.
  • November 2024: Lightcap is the quoted OpenAI spokesperson for the Muse partnership with Formation Bio (a Spark portfolio company). He is simultaneously the recusal proxy for Altman’s conflicts AND the public face of a commercial deal involving Spark’s investment.
  • April 2026: Lightcap moves from COO to “special projects” reporting directly to Altman. His new role specifically focuses on “complex deals and investments across the company,” including overseeing OpenAI’s push to sell software to businesses through joint ventures with private equity firms. The recusal proxy — the person who was supposed to act independently from Altman on conflicted deals — now reports directly to the person he is supposed to be independent from, and his new mandate is specifically to handle the “complex deals” that are most likely to involve conflicts [13].

The recusal mechanism assumes Lightcap can act independently from Altman’s interests. It does not account for Lightcap’s co-investment relationship with Spark (through the OpenAI Fund), his personal relationship with Kushner (forged during the crisis), or his April 2026 role change that places him directly under Altman’s supervision. The proxy is entangled with the very investors and structures he is supposed to be independent from.

Nodes / Open Questions

  • What is the current status of Spark’s Formation Bio position? Did the firm participate in Series C or Series D, or was involvement limited to the venture round?
  • Does Reed hold a board seat or observer rights at Formation Bio?
  • How does Spark manage information barriers between Razavi (Anthropic board) and Reed (Formation Bio, which partners with OpenAI)? Are there formal wall policies?
  • What is Fraser Kelton’s current scope at Spark? Does he have any involvement with the Formation Bio position or the OpenAI Startup Fund co-investment relationship?
  • The Descript co-investment alongside the OpenAI Startup Fund — does this create any ongoing LP or co-investor reporting relationship between Spark and the OpenAI Fund?
  • Spark invested in both Twitter and Discord. Both platforms have been channels for OpenAI/AI discourse and for clinical trial recruitment advertising. Any intersection with Formation Bio’s patient recruitment operations?
  • Welsh Carson Anderson & Stowe (Reed’s prior firm) — does Welsh Carson have any current positions in pharmaceutical companies that overlap with Formation Bio’s drug acquisition pipeline?
  • Spark’s growth fund ($1.4B, 2024) — does the growth fund hold any AI or healthcare positions that create additional conflicts beyond those documented here?
  • Lightcap moved to “special projects” under Altman in April 2026. Does this role change affect the recusal mechanism for any Spark-adjacent OpenAI commercial relationships?
  • Thrive AI Health (OpenAI Startup Fund + Huffington) operates in healthcare AI. Does it compete with, complement, or overlap Formation Bio’s Muse product?
  • Do any of Spark Capital’s LPs include pharmaceutical companies, health systems, or healthcare entities that could benefit from information flowing through the fund’s cross-competitive positions?

Sources

  1. [Archive] (https://en.wikipedia.org/wiki/Spark_Capital)
  2. [Archive] (https://news.crunchbase.com/venture/spark-capital-ai-anthropic/)
  3. [Archive] (https://www.willreed.fyi/)
  4. [Archive] (https://me.sh/profile/william-reed)
  5. [Archive] (https://www.linkedin.com/in/kareemzaki)
  6. [Archive] (https://techcrunch.com/2023/05/23/anthropic-raises-350m-to-build-next-gen-ai-assistants)
  7. [Archive] (https://anthropic.com/news/anthropic-series-c)
  8. [Archive] (https://en.wikipedia.org/wiki/Anthropic)
  9. [Archive] (https://voicebot.ai/2023/05/24/anthropic-raises-450m-to-accelerate-generative-ai-assistant-development/)
  10. [Archive] (https://techcrunch.com/2023/05/23/anthropic-raises-350m-to-build-next-gen-ai-assistants)
  11. [Archive] (https://ca.finance.yahoo.com/news/openai-startup-empire-companies-backed-140000784.html)
  12. [Archive] (https://www.openai.fund/about)
  13. [Archive] (https://techcrunch.com/2026/04/03/openai-executive-shuffle-new-roles-coo-brad-lightcap-fidji-simo-kate-rouch/)